$5.27 Nov 16, 2026 · market cap $215M
RxSight trades at $5.27. We don't have a valuation for it yet.
8 of 121 tracked investors hold it · Q2–Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app